http://feed.informer.com/digests/E3Q2DYR7OV/feeder nutrition_oncologie Respective post owners and feed distributors Thu, 04 Apr 2019 11:22:16 -0400 Feed Informer http://feed.informer.com/ https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175794653&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:0e2ca0a8-ab7f-0c36-9cf5-6dccba8b5c17 Wed, 01 May 2024 00:00:00 -0400 Nutrition & Cancer; 05/01/2024<br/>(AN 175794653); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175794658&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:ebf71f81-195d-c828-d1a6-81d7144aedd7 Wed, 01 May 2024 00:00:00 -0400 Nutrition & Cancer; 05/01/2024<br/>(AN 175794658); ISSN: 01635581<br/>CINAHL Complete http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&MODE=ovid&PAGE=fulltext&NEWS=n&D=emexb&AUTOALERT=322035376%7c1 nutrition_oncology_embase urn:uuid:40042a27-417f-e0ae-8578-b7a5597bd535 Sat, 06 Apr 2024 04:27:59 -0400 <div class="field" > <strong>Author Names:</strong> <span>Kranjcec I.,Pranjic I.,Roganovic J.,Pavlovic M.,Rajacic N.,Sila S.</span> </div> <div class="field" > <strong>Database Source:</strong> <span>Embase Weekly Updates</span> </div> <div class="field" > <strong>Journal Title:</strong> <span>Children</span> </div> <div class="field" > <strong>Article Title:</strong> <span><a href="http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;MODE=ovid&amp;PAGE=fulltext&amp;NEWS=n&amp;D=emexb&amp;AUTOALERT=322035376%7c1">Alterations of Nutritional Status in Children and Adolescents with Acute Lymphoblastic Leukemia</a></span> </div> <div class="field" > <strong>Year:</strong> <span>2024</span> </div> <div class="field" > <strong>Issue:</strong> <span>3</span> </div> <div class="field" > <strong>Volume:</strong> <span>11</span> </div> <div class="field" > <strong>Abstract:</strong> <span>Malnutrition is often observed in pediatric cancer patients and has been recognized as a risk factor for relapse and survival. Maintaining an appropriate nutritional status during anticancer treatment has, therefore, been more and more frequently perceived as an additional requirement for optimal therapy outcomes. The aim of our study was to establish alterations of nutritional status in 26 children and adolescents treated for acute lymphoblastic leukemia (ALL) at the Children&apos;s Hospital in Zagreb, Croatia, between 2016 and 2021, by using anthropometric measures and serum albumin levels. The majority of patients (53.8% female, median 4 years, 52.2% intermediate-risk leukemia group) had normal weight at the beginning of chemotherapy. The percentage of overweight/obese patients increased from 4.2% at diagnosis to 37.5% at the end of intensive therapy. Apart from a significant increase in body weight (BW) and body mass index (BMI) for age, a notable decline in body height/body length (BH/BL) for age in the observed period was recorded, especially in high-risk leukemia patients. The alterations in serum albumin values were not significant, nor was their correlation with BMI. Dietary consultation was offered to all patients, while children with a decline in BMI and BH/BL received additional nutritional support.&lt;br/&gt;Copyright &amp;#xa9; 2024 by the authors.</span> </div> http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&MODE=ovid&PAGE=fulltext&NEWS=n&D=emexb&AUTOALERT=322035376%7c2 nutrition_oncology_embase urn:uuid:530efa8c-1288-c4ee-4277-515c8190f510 Sat, 06 Apr 2024 04:27:59 -0400 <div class="field" > <strong>Author Names:</strong> <span>Gil-Andres D.,Cabanas-Alite L.</span> </div> <div class="field" > <strong>Database Source:</strong> <span>Embase Weekly Updates</span> </div> <div class="field" > <strong>Journal Title:</strong> <span>Nutrients,Nutrients</span> </div> <div class="field" > <strong>Article Title:</strong> <span><a href="http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;MODE=ovid&amp;PAGE=fulltext&amp;NEWS=n&amp;D=emexb&amp;AUTOALERT=322035376%7c2">A Narrative Review Comparing Nutritional Screening Tools in Outpatient Management of Cancer Patients</a></span> </div> <div class="field" > <strong>Year:</strong> <span>2024</span> </div> <div class="field" > <strong>Issue:</strong> <span>5</span> </div> <div class="field" > <strong>Volume:</strong> <span>16</span> </div> <div class="field" > <strong>Abstract:</strong> <span>Malnutrition during cancer has a negative impact on prognosis and quality of life. Therefore, it is important to identify those patients at higher nutritional risk to prevent its development. There are nutritional screening tools, such as MUST and NRS-2002, that focus on the patient on admission to hospital. However, most patients will develop malnutrition in the outpatient or ambulatory setting. This study aims to determine which nutritional screening tool is most effective in assessing nutritional risk in the outpatient oncology patient, highlighting the parameters analysed by these tools. Seventeen articles were reviewed, with the most important variables being tumour location, tumour stage, age, and gender, as well as recent weight loss, dietary intake, and digestive disorders. The Nutriscore, NRS-2002, and MUST tools are considered suitable, but the choice varies depending on these parameters. MNA is suitable for elderly patients, while SNAQ was not considered reliable in this population. In conclusion, MUST, NRS-2002, and Nutriscore are suitable tools, but their choice depends on specific characteristics. There is currently no universal tool for nutritional risk assessment in outpatients.&lt;br/&gt;Copyright &amp;#xa9; 2024 by the authors.</span> </div> http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&MODE=ovid&PAGE=fulltext&NEWS=n&D=emexb&AUTOALERT=322035376%7c3 nutrition_oncology_embase urn:uuid:293f4103-a52c-6333-6e9e-82438166b1bc Sat, 06 Apr 2024 04:27:59 -0400 <div class="field" > <strong>Author Names:</strong> <span>Samper Ots P.M.,Rodriguez de la Pena J.,Chaves Pantoja C.J.,Moreno Cerrato N.,Campos Lopez E.,Martin Lopez M.,De Las Penas Cabrera M.D.,Payano Hernandez S.,Amaya Escobar E.,Zapatero Ortuno J.,Garcia Torres C.</span> </div> <div class="field" > <strong>Database Source:</strong> <span>Embase Weekly Updates</span> </div> <div class="field" > <strong>Journal Title:</strong> <span>Journal of Geriatric Oncology</span> </div> <div class="field" > <strong>Article Title:</strong> <span><a href="http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;MODE=ovid&amp;PAGE=fulltext&amp;NEWS=n&amp;D=emexb&amp;AUTOALERT=322035376%7c3">Impact of radical radiotherapy on nutritional status and functional capacity in elderly patients</a></span> </div> <div class="field" > <strong>Year:</strong> <span>2023</span> </div> <div class="field" > <strong>Issue:</strong> <span>8 Supplement 1</span> </div> <div class="field" > <strong>Volume:</strong> <span>14</span> </div> <div class="field" > <strong>Abstract:</strong> <span>Introduction: Elderly cancer patients may have functional impairment and loss of muscle mass due to aging and are more vulnerable to cancer treatment. &lt;br/&gt;Objective(s): To determine whether radical radiotherapy (RT), with or without chemotherapy (QT), has an impact on the physical, functional and nutritional status of the elderly patients. &lt;br/&gt;Method(s): Prospective unicentric observational study. Inclusion criteria: Cancer patients &gt;= 70 years old, radical RT treatment, ECOG 0-1, with capacity to collaborate in the study and informed consent. Demographic, anthropometric, bioimpedancemetry, dynamometry, risk of frailty (G8), assessment of functional capacity (SPPB) and risk of falls, risk of sarcopenia (SARC_F), risk of malnutrition (Nutriscore), and patient-reported quality of life (QoL) (EORTC_QLQ_C30) data at baseline and at the end of treatment. Statistical analysis with SPSS version 26. &lt;br/&gt;Result(s): The first 25 patients included in the study that have already completed RT are presented. Mean age 76.4 years, 20 (80%) males, 20 (80%) ECOG 0. Prostate cancer 17 (68%). 18 (72%) IADL. 10 (40%)were at risk of frailty (G8 &lt;= 14).19 (76%) no nutritional risk.19 (76%) no risk of sarcopenia. Activity level: inactive 9 (36%) and occasional low-intensity exercise 16 (64%). Functional assessment: autonomous 13 (52%), prefragile 10 (40%) and fragile 2 (8%). With RT, no significant differences were observed in QoL, but a significant decrease in G8, weight, % body fat, BMI, metabolic age and the time up and go was observed, whereas and a significant increase in bone mass, % body water, and SPPB were registred (Table 1). &lt;br/&gt;Conclusion(s): Despite the small sample size, RT does not seem to produce a detrimental effect on the functional capacity of elderly patients. [Figure presented]&lt;br/&gt;Copyright &amp;#xa9; 2023 Elsevier Ltd. All rights reserved.</span> </div> http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&MODE=ovid&PAGE=fulltext&NEWS=n&D=emexb&AUTOALERT=322035376%7c4 nutrition_oncology_embase urn:uuid:9b0429fc-9541-1879-2eac-c5406d49aa7a Sat, 06 Apr 2024 04:27:59 -0400 <div class="field" > <strong>Author Names:</strong> <span>Cai B.,Luo L.,Zhu C.,Meng L.,Shen Q.,Fu Y.,Wang M.,Chen S.</span> </div> <div class="field" > <strong>Database Source:</strong> <span>Embase Weekly Updates</span> </div> <div class="field" > <strong>Journal Title:</strong> <span>Frontiers in Oncology,Frontiers in Oncology</span> </div> <div class="field" > <strong>Article Title:</strong> <span><a href="http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;MODE=ovid&amp;PAGE=fulltext&amp;NEWS=n&amp;D=emexb&amp;AUTOALERT=322035376%7c4">Corrigendum: Influence of body composition assessment with bioelectrical impedance vector analysis in cancer patients undergoing surgery (Frontiers in Oncology, (2023), 13, (1132972), 10.3389/fonc.2023.1132972)</a></span> </div> <div class="field" > <strong>Year:</strong> <span>2024</span> </div> <div class="field" > <strong>Issue:</strong> <span></span> </div> <div class="field" > <strong>Volume:</strong> <span>14</span> </div> <div class="field" > <strong>Abstract:</strong> <span>In the published article, there was an error. The model of the instrument of body composition analysis and alternating sinusoidal electric was wrong. A correction has been made to 2. Materials and methods, 2.3 Anthropometry and body composition measurement, Paragraph 2. This sentence previously stated: &quot;Body composition analysis was performed using the bioelectrical impedance vector analysis method with BIA 101 BIVA&lt;sup&gt;&lt;/sup&gt; PRO instrument (Akern/RJL) which applies alternating sinusoidal electric currents of 250 microA at an operating frequency of 50 kHz.&quot; The corrected sentence appears below: &quot;Body composition analysis was performed using the Bioelectrical Impedance Analysis (BIA, NUTRILAB, AKERN, Italy) which applies alternating sinusoidal electric currents of 400 microA at an operating frequency of 50 kHz.&quot; The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.&lt;br/&gt;Copyright &amp;#xa9; 2024 Cai, Luo, Zhu, Meng, Shen, Fu, Wang and Chen.</span> </div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176165387&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:85f59948-62ac-65f4-d5c5-6e751dc087d5 Mon, 01 Apr 2024 00:00:00 -0400 Clinical Journal of Oncology Nursing; 04/01/2024<br/>(AN 176165387); ISSN: 10921095<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175827299&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:d2c81811-9831-252a-d906-22656a63c192 Mon, 01 Apr 2024 00:00:00 -0400 Nutrition in Clinical Practice; 04/01/2024<br/>(AN 175827299); ISSN: 08845336<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/38537971/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:8e64e12f-e049-f4db-61c0-9d5a2dcdeb15 Tue, 26 Mar 2024 20:00:00 -0400 CONCLUSION: Preoperative PNI is a prognostic factor for both OS and RFS in patients with pancreatic cancer who underwent perioperative adjuvant chemotherapy and surgical resection. This study suggests that a low PNI may cause a lack of full-dose adjuvant chemotherapy, leading to recurrence and resulting in a poor prognosis for surgical pancreatic cancer patients treated with perioperative adjuvant chemotherapy. <div><p style="color: #4aa564;">Anticancer Res. 2024 Apr;44(4):1711-1718. doi: 10.21873/anticanres.16970.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND/AIM: The prognostic nutritional index (PNI) is used as a marker to evaluate the nutritional and immunological status of patients with various cancers. This study aimed to investigate whether preoperative PNI is a prognostic factor in patients with pancreatic cancer who underwent perioperative adjuvant chemotherapy and surgical resection.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PATIENTS AND METHODS: We retrospectively enrolled 232 pancreatic cancer patients who underwent surgical resection with perioperative adjuvant chemotherapy between January 2013 and December 2022. Overall survival (OS) and relapse-free survival (RFS) rates were calculated using the Kaplan-Meier method. Univariate and multivariate analyses were performed using the Cox proportional hazards regression models.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The optimal cutoff value for the preoperative PNI was 44.3 in the present study. PNI &lt;44.3 was associated with older age (p&lt;0.001) and affected the clinical course of postoperative adjuvant chemotherapy. The PNI &lt;44.3 had an important influence on the decreased OS (25.1 vs. 39.0 months) and RFS (13.1 vs. 22.8 months). In univariate and multivariate analyses, the preoperative PNI was an independent prognostic factor for OS [hazard ratio (HR)=1.682, 95% confidence interval (CI)=1.059-2.673, p=0.028] and RFS (HR=1.559, 95% CI=1.037-2.344, p=0.033).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Preoperative PNI is a prognostic factor for both OS and RFS in patients with pancreatic cancer who underwent perioperative adjuvant chemotherapy and surgical resection. This study suggests that a low PNI may cause a lack of full-dose adjuvant chemotherapy, leading to recurrence and resulting in a poor prognosis for surgical pancreatic cancer patients treated with perioperative adjuvant chemotherapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38537971/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38537971</a> | DOI:<a href=https://doi.org/10.21873/anticanres.16970>10.21873/anticanres.16970</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176306995&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:bf3f9bdc-671c-bab8-b8ae-8cc5bd87deec Fri, 15 Mar 2024 00:00:00 -0400 Cancers; 03/15/2024<br/>(AN 176306995); ISSN: 20726694<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176304029&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:d04f2616-f1b0-c88f-d1af-488bf6e1312a Fri, 01 Mar 2024 00:00:00 -0500 Children; 03/01/2024<br/>(AN 176304029); ISSN: 22279067<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175725225&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:7fa9a4e8-ac93-7d6c-270d-91765bbab01c Fri, 01 Mar 2024 00:00:00 -0500 Clinical Nutrition; 03/01/2024<br/>(AN 175725225); ISSN: 02615614<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175991654&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:a8f87c82-aecc-adfb-5163-7f71af9b0afc Fri, 01 Mar 2024 00:00:00 -0500 Nutrients; 03/01/2024<br/>(AN 175991654); ISSN: 20726643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175879871&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:db26c7e7-61b6-4a9c-9ca5-bddda340bf66 Fri, 01 Mar 2024 00:00:00 -0500 Oncology Nursing Forum; 03/01/2024<br/>(AN 175879871); ISSN: 0190535X<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176191874&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:0eab7ed8-477a-2194-9859-e9e2a4632dee Fri, 01 Mar 2024 00:00:00 -0500 Positive Health; 03/01/2024<br/>(AN 176191874); ISSN: 13563963<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/38400912/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:e356c084-8f31-2bb2-1937-836d68dd6a21 Fri, 23 Feb 2024 19:00:00 -0500 CONCLUSION: Patients consistently demonstrated improvements in nutritional risk and status from the initiation to the completion of chemotherapy cycles. Nutritional monitoring of OC women, particularly those exhibiting abnormalities at the commencement of chemotherapy, is crucial. Targeted nutritional support programs should be developed to enhance the prognosis of OC women. <div><p style="color: #4aa564;">Support Care Cancer. 2024 Feb 24;32(3):191. doi: 10.1007/s00520-024-08384-8.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PURPOSE: Numerous studies have investigated the relationships between nutritional status and the prognosis of ovarian cancer (OC). However, the majority of these studies have focused on pre-chemotherapy malnutrition, with limited attention given to dynamic changes in nutritional status during chemotherapy and the associated risk factors affecting the prognostic nutritional index (PNI) in OC women. This study aims to explore the variation trend in the nutritional status of OC women over time during chemotherapy and assess its predictive factors.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A prospective longitudinal study was conducted from January 2021 to August 2023. Body mass index (BMI), PNI, Nutritional Risk Screening (NRS) 2002, serum albumin, and prealbumin measurements were utilized to assess the nutritional status of OC women. Data were collected through face-to-face interviews before initial chemotherapy (T0) and during the first (T1), third (T2), and fifth (T3) cycles of chemotherapy. Generalized Estimating Equations (GEE) were employed for the analysis of potential predictive factors.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 525 OC women undergoing chemotherapy completed the study. Significantly varied levels of BMI, PNI, and serum concentrations of hemoglobin, albumin, prealbumin, potassium, sodium, magnesium, and calcium were observed in these patients (p &lt; 0.05). The prevalence of nutritional risk decreased over time during chemotherapy (p &lt; 0.05). Nutritional parameters, including BMI, PNI, and the serum concentrations of albumin and prealbumin, exhibited an upward trend in nutritional status throughout the chemotherapy cycles (p &lt; 0.05). Multivariate analysis indicated that higher levels of BMI, serum albumin, prealbumin, absolute lymphocyte count, and hemoglobin ≥ 110 g/L at admission were associated with elevated PNI after chemotherapy (β = 0.077, p = 0.028; β = 0.315, p &lt; 0.001; β = 0.009, p &lt; 0.001; β = 1.359, p &lt; 0.001; β = - 0.637, p = 0.005).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Patients consistently demonstrated improvements in nutritional risk and status from the initiation to the completion of chemotherapy cycles. Nutritional monitoring of OC women, particularly those exhibiting abnormalities at the commencement of chemotherapy, is crucial. Targeted nutritional support programs should be developed to enhance the prognosis of OC women.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38400912/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38400912</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10894134/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">PMC10894134</a> | DOI:<a href=https://doi.org/10.1007/s00520-024-08384-8>10.1007/s00520-024-08384-8</a></p></div> https://pubmed.ncbi.nlm.nih.gov/38396102/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:19b44d9c-31ed-1091-1ca5-7f14c7213517 Thu, 22 Feb 2024 19:00:00 -0500 CONCLUSION: This study identified disparities in the methodological quality of the included CPGs, particularly in the "Applicability" domain, thus emphasizing the need for advancement in clinical feasibility and implementation. Notably, there is few guidelines specifically targeting colorectal cancer nutrition. These synthesized findings provided an intuitive, convenient, and comprehensive reference for evaluating nutrition among colorectal cancer patients. When applying these results, users... <div><p style="color: #4aa564;">Support Care Cancer. 2024 Feb 24;32(3):187. doi: 10.1007/s00520-024-08394-6.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PURPOSE: The aim of this study is to rigorously assess the methodological quality of published clinical practice guidelines (CPGs) related to nutrition among colorectal cancer patients, to compile consensus recommendations, and to evaluate the quality of the included CPGs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The systematic search covered eight electronic databases, two relevant professional association websites, and six guideline websites from their inception up to January 22, 2023. The methodological quality of the eligible guidelines was evaluated using the Appraisal of Guidelines Research and Evaluation II (AGREE II) instrument, and then, consensus recommendations were synthesized. The scores for each domain were expressed as the mean ± standard deviation (SD). Using the mean score as the benchmark for comparison, they were subsequently ranked from highest to lowest. The included guidelines were then categorized as having "high," "moderate," or "low" quality based on their scores.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The literature search yielded ten guidelines. The findings indicated that the "Clarity of presentation" domain had the highest mean score (65.2 ± 7.7). This demonstrates how the guidelines effectively articulate recommendations. Additionally, the "Scope and purpose" domain achieved a mean score of 60.7 ± 10.9, followed by "Rigor of development" (51.7 ± 15.7), "Editorial independence" (51.1 ± 21), "Stakeholder involvement" (48 ± 16.8), and "Applicability" domains (47.5 ± 17.3). Two CPGs received an overall rating of "high quality" and were recommended; four CPGs received an overall rating of "moderate" and were recommended with modifications; and four CPGs received an overall rating of "low quality" and were not recommended. Furthermore, this study compiled twenty consensus recommendations related to nine distinct clinical issues.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This study identified disparities in the methodological quality of the included CPGs, particularly in the "Applicability" domain, thus emphasizing the need for advancement in clinical feasibility and implementation. Notably, there is few guidelines specifically targeting colorectal cancer nutrition. These synthesized findings provided an intuitive, convenient, and comprehensive reference for evaluating nutrition among colorectal cancer patients. When applying these results, users should make careful decisions based on their specific situations.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38396102/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38396102</a> | DOI:<a href=https://doi.org/10.1007/s00520-024-08394-6>10.1007/s00520-024-08394-6</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175373889&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:28600933-5cf3-53a5-df87-97b0b2a2a5b7 Thu, 01 Feb 2024 00:00:00 -0500 Cancers; 02/01/2024<br/>(AN 175373889); ISSN: 20726694<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175454233&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:b75eab6a-347d-a878-420f-b39cd19601ac Thu, 01 Feb 2024 00:00:00 -0500 European Journal of Oncology Nursing; 02/01/2024<br/>(AN 175454233); ISSN: 14623889<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175369084&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:4b0028c5-6e14-13dc-8cdb-9402cabf5dfd Thu, 01 Feb 2024 00:00:00 -0500 Nutrients; 02/01/2024<br/>(AN 175369084); ISSN: 20726643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=174869795&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:d9f30b7d-a267-c97b-2499-a06df1e94c04 Mon, 01 Jan 2024 00:00:00 -0500 Oncology; 01/01/2024<br/>(AN 174869795); ISSN: 00302414<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/38160005/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:975990ec-d982-b296-2852-4d238ab099fb Fri, 29 Dec 2023 19:00:00 -0500 CONCLUSION: Pre-operative GNRI may predict complete AC and prognosis in resected pancreatic cancer. <div><p style="color: #4aa564;">Anticancer Res. 2024 Jan;44(1):427-434. doi: 10.21873/anticanres.16828.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND/AIM: The Geriatric Nutritional Risk Index (GNRI) predicts prognosis in various cancers. This study examined the correlation between GNRI, complete adjuvant chemotherapy (AC), and prognosis in patients with resected pancreatic cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PATIENTS AND METHODS: We retrospectively evaluated 123 patients with pancreatic cancer who underwent pancreatectomies at our institute between January 2010 and December 2020. Kaplan-Meier and Cox regression methods were used to assess survival. Factors associated with complete AC were identified using logistic regression analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among the 123 patients with pancreatic cancer, 93 (75.6%) initiated AC, and 55 (44.7%) completed AC. In multivariate analysis, the pre-operative GNRI was an independent prognostic factor for overall survival (OS) [hazard ratio=1.63, 95% confidence interval (CI)=1.01-2.63; p=0.046]. Additionally, pre-operative GNRI was an independent predictor of complete AC (odds ratio=0.38, 95%CI=0.17-0.83; p=0.015). In the high (≥98) and low GNRI (&lt;98) groups, patients who underwent complete AC had significantly longer OS than those who did not (p&lt;0.001, respectively). However, the patients in the low GNRI group who underwent complete AC had no significant difference in OS compared to those in the high GNRI group who did not undergo complete AC (p=0.523).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Pre-operative GNRI may predict complete AC and prognosis in resected pancreatic cancer.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38160005/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38160005</a> | DOI:<a href=https://doi.org/10.21873/anticanres.16828>10.21873/anticanres.16828</a></p></div> https://pubmed.ncbi.nlm.nih.gov/38113874/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:80d847eb-ce8e-0326-b27a-51862e9ee7ef Mon, 18 Dec 2023 19:00:00 -0500 Colorectal cancer (CRC) is one of the most common cancers worldwide and it involves various biomolecular and cellular levels. CRC has possibly happened due to aging, urbanization, and diet. Different foods have varying effects on the gastrointestinal cells, that's why additional research is necessary to create effective medical interventions. This review aimed to evaluate the correlation between dietary and nutritional status on the outcome of CRC patients. Study results showed that a healthy... <div><p style="color: #4aa564;">Ann Med. 2023;55(2):2281662. doi: 10.1080/07853890.2023.2281662. Epub 2023 Dec 19.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Colorectal cancer (CRC) is one of the most common cancers worldwide and it involves various biomolecular and cellular levels. CRC has possibly happened due to aging, urbanization, and diet. Different foods have varying effects on the gastrointestinal cells, that's why additional research is necessary to create effective medical interventions. This review aimed to evaluate the correlation between dietary and nutritional status on the outcome of CRC patients. Study results showed that a healthy diet such as fruit and vegetables is the best diet for improving colorectal cancer outcomes. Moreover, nutritional status affected CRC patients' outcomes, where high BMI increases the risk of having CRC. However, low BMI was associated with CRC progression and poor quality of life.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38113874/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38113874</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10986434/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">PMC10986434</a> | DOI:<a href=https://doi.org/10.1080/07853890.2023.2281662>10.1080/07853890.2023.2281662</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=174469933&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:cdca1299-f8be-c4f7-c5af-73c9ccfd6f33 Fri, 15 Dec 2023 00:00:00 -0500 Nutrients; 12/15/2023<br/>(AN 174469933); ISSN: 20726643<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/38095717/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:7f975726-2473-1b4a-6b90-24260fa6f2b1 Wed, 13 Dec 2023 19:00:00 -0500 CONCLUSION: This study underscores the pressing need for unified recommendations to improve nutritional care and potentially enhance outcomes for pediatric cancer patients. <div><p style="color: #4aa564;">Eur J Pediatr. 2024 Mar;183(3):1137-1144. doi: 10.1007/s00431-023-05368-4. Epub 2023 Dec 14.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Nutritional status plays a crucial role in the mortality rates of the pediatric oncology patients. However, there is a lack of systematic approaches for nutritional assessment in this population. This study aims to assess the current practice for nutritional assessment and care of pediatric cancer patients in Italy. A 25-items web-based, nation-wide questionnaire was circulated as of January 9, 2023 among physicians within the AIEOP network, composed of 49 national centers, out of which 21 routinely perform HCT. This survey examined the practices of 21 Italian pediatric oncology centers, revealing significant heterogeneity in nutritional practices. Only half of the centers routinely assessed all patients, utilizing different clinical and biochemical parameters. The use of neutropenic diets remained prevalent after chemotherapy or stem cell transplantation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This study underscores the pressing need for unified recommendations to improve nutritional care and potentially enhance outcomes for pediatric cancer patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">WHAT IS KNOWN: • The assessment and support of nutrition are gaining interest in the overall care of children with cancer. • The assessment and management of nutritional needs in pediatric cancer patients, including those undergoing hematopoietic cell transplantation, currently lack a systematic approach.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">WHAT IS NEW: • There is considerable variability in the nutritional assessment and support among Italian centers treating pediatric patients with cancer. • To enhance nutritional assessment and support for pediatric cancer patients, it is essential to establish shared national and international guidelines.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38095717/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38095717</a> | DOI:<a href=https://doi.org/10.1007/s00431-023-05368-4>10.1007/s00431-023-05368-4</a></p></div> https://pubmed.ncbi.nlm.nih.gov/38068818/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:012e715a-4905-6455-78ca-a296815c85e6 Fri, 08 Dec 2023 19:00:00 -0500 CONCLUSIONS: It is crucial to consider the nutritional status of breast cancer patients, alongside clinical factors, to offer comprehensive and personalized care. Gaining insight into the sociodemographic variables linked to nutritional risk can significantly contribute to our understanding of breast cancer. This knowledge, in turn, can aid in identifying effective strategies for public policy, health promotion, and prevention efforts aimed at tackling this condition. <div><p style="color: #4aa564;">Nutrients. 2023 Nov 29;15(23):4961. doi: 10.3390/nu15234961.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Breast cancer poses a significant public health concern owing to its high prevalence and the risk of mortality associated with delayed diagnosis and treatment. The aim of this study was to assess the nutritional status of women with non-metastatic breast cancer and to identify factors associated with it.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A cross-sectional observational study was conducted at a High Complexity Oncology Assistance Center in the southeast region of Brazil, with the aim of assessing the nutritional status in women undergoing treatment for stage I, II, or III breast cancer. Patients in palliative care or undergoing reconstructive surgery were excluded. Data collection took place between June 2022 and March 2023 and included questionnaires, physical examinations, laboratory tests, and anthropometric assessments. Nutritional status was assessed using measures such as BMI and skinfold thickness, while nutritional risk was assessed using the Nutritional Risk Screening (NRS-2002) tool.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Significant associations were found between nutritional risk and educational level (<i>p</i> = 0.03) and BMI (<i>p</i> = 0.01). Binary logistic regression analysis revealed a significant association between educational level and nutritional risk, indicating that lower educational level was associated with higher odds of nutritional risk (OR = 4.59; 95% CI = 1.01-21.04; <i>p</i> = 0.049). In addition, regarding BMI, it was observed that a BMI above 20.5 kg/m² was associated with a higher likelihood of nutritional risk (OR = 0.09; 95% CI = 0.01-0.89; <i>p</i> = 0.039).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: It is crucial to consider the nutritional status of breast cancer patients, alongside clinical factors, to offer comprehensive and personalized care. Gaining insight into the sociodemographic variables linked to nutritional risk can significantly contribute to our understanding of breast cancer. This knowledge, in turn, can aid in identifying effective strategies for public policy, health promotion, and prevention efforts aimed at tackling this condition.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38068818/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38068818</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10707825/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">PMC10707825</a> | DOI:<a href=https://doi.org/10.3390/nu15234961>10.3390/nu15234961</a></p></div> https://pubmed.ncbi.nlm.nih.gov/38065853/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:9fdf9071-db33-ee48-c03b-809fc544e0ca Thu, 07 Dec 2023 19:00:00 -0500 CONCLUSION: The Home to Hospital to Home nutrition management program improves the nutritional status of postoperative liver cancer patients, lowers the incidence of complications, shortens hospital stays, increases patient satisfaction, and promotes the early recovery of patients. <div><p style="color: #4aa564;">Medicine (Baltimore). 2023 Dec 8;102(49):e36648. doi: 10.1097/MD.0000000000036648.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Malnutrition is the most common complication in postoperative liver cancer patients. This study aimed to investigate the effects of the Home to Hospital to Home nutrition management program on postoperative liver cancer patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A total of 184 liver cancer patients were randomly assigned to either an intervention group (treated under the Home to Hospital to Home nutrition management program) or a control group (treated with the general nutritional method). Nutrition-related indicators, such as prealbumin (PA) and albumin, were assessed before and after treatment in both groups. The incidence of complications (e.g., nausea or vomiting, bloating, difficulty defecating, ascites), length of hospital stay, first time to anal exhaust and out-of-bed activity, and patient satisfaction were recorded.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 184 liver cancer patients were randomly assigned to either an intervention group (treated under the Home to Hospital to Home nutrition management program) or a control group (treated with the general nutritional method). Nutrition-related indicators, such as prealbumin (PA) and albumin, were assessed before and after treatment in both groups. The incidence of complications (e.g., nausea or vomiting, bloating, difficulty defecating, ascites), length of hospital stay, first time to anal exhaust and out-of-bed activity, and patient satisfaction were recorded.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The Home to Hospital to Home nutrition management program improves the nutritional status of postoperative liver cancer patients, lowers the incidence of complications, shortens hospital stays, increases patient satisfaction, and promotes the early recovery of patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38065853/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38065853</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10713131/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">PMC10713131</a> | DOI:<a href=https://doi.org/10.1097/MD.0000000000036648>10.1097/MD.0000000000036648</a></p></div> https://pubmed.ncbi.nlm.nih.gov/38055054/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:b87c669e-c501-c063-a380-2eb910537977 Tue, 05 Dec 2023 19:00:00 -0500 CONCLUSIONS: The three scoring methods had a high predictive value for the prognosis of patients with laryngeal cancer, with GPS having the strongest correlation with the prognosis of laryngeal cancer patients. <div><p style="color: #4aa564;">Support Care Cancer. 2023 Dec 2;31(12):737. doi: 10.1007/s00520-023-08148-w.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Several studies have found that the prognostic nutritional index (PNI), controlling nutritional status (CONUT), and Glasgow Prognostic Score (GPS) of patients with laryngeal cancer accurately predict their prognosis. However, there is no consensus regarding the best assessment tool. Therefore, this study aimed to confirm the predictive value of the three nutritional scoring systems for the prognosis of patients with laryngeal cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This study analyzed a cohort of 427 patients with laryngeal cancer who visited our hospital. PNI, CONUT, and GPS were calculated, and the relationship between these indicators and prognosis was examined.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The optimal cut-off levels for overall survival (OS) of laryngeal cancer patients determined by PNI, CONUT, and GPS were 45, 3, and 0, respectively. When patients were stratified based on these thresholds, OS and disease-free survival (DFS) were significantly decreased in the malnutrition group (all three, p &lt; 0.05). The OS rates of patients with laryngeal cancer were significantly affected by the three scores according to multivariate analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The three scoring methods had a high predictive value for the prognosis of patients with laryngeal cancer, with GPS having the strongest correlation with the prognosis of laryngeal cancer patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38055054/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38055054</a> | DOI:<a href=https://doi.org/10.1007/s00520-023-08148-w>10.1007/s00520-023-08148-w</a></p></div> https://pubmed.ncbi.nlm.nih.gov/38043419/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:1907124d-6e5e-51b6-7666-5f2e4af16176 Sat, 02 Dec 2023 19:00:00 -0500 CONCLUSION: Our study indicated the relevance of nutritional status to the efficacy and prognosis of advanced EC patients treated with ICIs. The pretreatment levels of Hb and BMI were significantly related to therapeutic response. The pretreatment levels of Hb, BMI, ALB, PAB, TRF, and PNI were partially associated with survival. Notably, Hb is not only related to therapeutic response but is also an independent prognostic indicator of survival outcomes. <div><p style="color: #4aa564;">Clin Nutr. 2024 Jan;43(1):142-153. doi: 10.1016/j.clnu.2023.11.030. Epub 2023 Nov 27.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND & AIMS: Malnutrition is reported in 60%-85% of oesophageal cancer (EC) patients. Indicators commonly used in the clinic to evaluate the nutritional status of patients include haemoglobin (Hb), body mass index (BMI), albumin (ALB), prognostic nutritional index (PNI), prealbumin (PAB), transferrin (TRF), and NRS2002 scores. In this study, we explored the associations between pretreatment nutrition-related indicators and clinical outcomes in patients with advanced EC who were treated with immune checkpoint inhibitors (ICIs).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The general clinical data of patients, NRS2002 scores, PNI, and levels of BMI, ALB, Hb, PAB, and TRF at baseline were collected. Categorical variables were compared using the chi-squared test. The chi-squared test was used to compare the differences in the objective response rate (ORR) and the disease control rate (DCR) between groups. The Kaplan-Meier method was used to compute the survival curves. Cox proportional hazard regression was performed to evaluate factors independently associated with OS and PFS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULT: Of the 1340 patients diagnosed with EC at Zhejiang Cancer Hospital between June 2018 and September 2022, 354 patients with advanced EC who underwent ICI therapy were enrolled. In total, the ORR and DCR were 38.1% and 82.2%, respectively. A significantly worse response to ICI therapy was observed in the Hb-L group and the BMI-L group. The median PFS and OS among all enrolled patients were 6.0 months and 13.3 months, respectively. PFS was significantly associated with pretreatment levels of Hb, ALB, and PAB. OS was significantly associated with pretreatment levels of Hb, ALB, BMI, PNI, TRF, and PAB. The multivariate analysis further demonstrated that Hb was an independent prognostic factor of both OS (P = 0.004) and PFS (P = 0.047), and ALB was an independent prognostic factor of OS (P = 0.045). No independent relevance for OS or PFS was found in the BMI, PNI, TRF, or PAB groups. In this study, the NRS2002 scores was not significantly correlated with the therapeutic response or prognosis of ICI therapy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Our study indicated the relevance of nutritional status to the efficacy and prognosis of advanced EC patients treated with ICIs. The pretreatment levels of Hb and BMI were significantly related to therapeutic response. The pretreatment levels of Hb, BMI, ALB, PAB, TRF, and PNI were partially associated with survival. Notably, Hb is not only related to therapeutic response but is also an independent prognostic indicator of survival outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38043419/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38043419</a> | DOI:<a href=https://doi.org/10.1016/j.clnu.2023.11.030>10.1016/j.clnu.2023.11.030</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173748096&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:71bb639c-f2da-94b6-b318-65a61b1d2953 Fri, 01 Dec 2023 00:00:00 -0500 Archives of Physical Medicine & Rehabilitation; 12/01/2023<br/>(AN 173748096); ISSN: 00039993<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=174112190&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:fe0a0b80-ae5e-007d-7077-beb9f8363003 Fri, 01 Dec 2023 00:00:00 -0500 Nutrients; 12/01/2023<br/>(AN 174112190); ISSN: 20726643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=174109482&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:adbc8be2-01ad-7d6d-0742-95c08f8427dd Fri, 01 Dec 2023 00:00:00 -0500 Oncology Nurse-APN/PA; 12/01/2023<br/>(AN 174109482); ISSN: 19449801<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/38038415/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:e0b3a96e-c31c-e03d-cba1-33b1229c1835 Thu, 30 Nov 2023 19:00:00 -0500 CONCLUSIONS: Lower phase angle values before surgery were associated with more complications during the first month after surgery and longer hospitalization time. We found that a phase angle below than 5.5° could serve as a marker that predicts a greater risk of postoperative complications. <div><p style="color: #4aa564;">Radiol Oncol. 2023 Nov 30;57(4):524-529. doi: 10.2478/raon-2023-0060. eCollection 2023 Dec 1.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: In patients with gastrointestinal cancer with planned elective surgery, malnutrition increases the risk of adverse outcomes in the postoperative period. The phase angle, measured by the bioelectrical impedance analysis is an indicator of the metabolic and functional status of the patient. It may be an important prognostic indicator for the clinical outcome of post-surgical treatment in patients with gastrointestinal cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PATIENTS AND METHODS: In this prospective study, 70 patients with gastrointestinal cancer had their phase angles measured by the bioelectrical impedance analysis before the surgery. During the first month after the surgery, we documented the postoperative complications from the patient's records and classified them according to the Clavien Dindo classification of surgical complications. The time of hospitalization was also recorded. The data was statistically analysed in SPSS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We found a statistically significant difference (p = 0.036) in the average value of phase angles between the group of patients who had postoperative complications (phase angle 5.09°) and the group without postoperative complications (5.64°). We noted a correlating trend of decreasing phase angle values and increasing hospitalization time (Pe R = -0,40, p = 0,001). The phase angle cut-off value (5.5°) was calculated using the ROC curve method, predicting a higher risk of the postoperative complications (p = 0,037) in patients with lower phase angle.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Lower phase angle values before surgery were associated with more complications during the first month after surgery and longer hospitalization time. We found that a phase angle below than 5.5° could serve as a marker that predicts a greater risk of postoperative complications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38038415/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">38038415</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10690749/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">PMC10690749</a> | DOI:<a href=https://doi.org/10.2478/raon-2023-0060>10.2478/raon-2023-0060</a></p></div> https://pubmed.ncbi.nlm.nih.gov/37853186/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:4eda659e-4fb3-717b-56fe-5ac91564d3ba Tue, 17 Oct 2023 20:00:00 -0400 Cancer is a leading cause of death globally. Immunotherapy has shown promise in treating various types of cancer, but its effectiveness varies among patients. The Controlling Nutritional Status (CONUT) score has been linked to the prognosis of different cancers. However, its predictive value for immunotherapy outcomes is not well understood. Our research represents the pioneering meta-study to examine the prognostic value of the CONUT score on cancer patients treated with an immune checkpoint... <div><p style="color: #4aa564;">Sci Rep. 2023 Oct 18;13(1):17715. doi: 10.1038/s41598-023-45096-1.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cancer is a leading cause of death globally. Immunotherapy has shown promise in treating various types of cancer, but its effectiveness varies among patients. The Controlling Nutritional Status (CONUT) score has been linked to the prognosis of different cancers. However, its predictive value for immunotherapy outcomes is not well understood. Our research represents the pioneering meta-study to examine the prognostic value of the CONUT score on cancer patients treated with an immune checkpoint inhibitor (ICI). A comprehensive literature search was conducted using various databases including PubMed, the Cochrane Library, EMBASE, and Google Scholar. The study was conducted until July 28, 2023. This analysis encompassed a comprehensive evaluation of various clinical outcomes, namely overall survival (OS), progression-free survival (PFS), objective response rate (ORR), and disease control rate (DCR). 663 patients from 8 studies were included in this study. It showed that cancer patients with high CONUT score had poorer OS (HR: 1.94, 95% CI, 1.52-2.47, p &lt; 0.001) and PFS (HR: 2.22, 95% CI, 1.48-3.31, p &lt; 0.001), as well as worse ORR (OR: 0.46, 95% CI, 0.25-0.85, p = 0.013) and DCR (HR: 0.29, 95% CI, 0.14-0.59, p = 0.001). The CONUT score can predict the prognosis of tumor patients treated with ICIs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37853186/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">37853186</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10584918/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">PMC10584918</a> | DOI:<a href=https://doi.org/10.1038/s41598-023-45096-1>10.1038/s41598-023-45096-1</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173309653&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:ad1fd20a-e07f-acd4-faaa-82c388306c19 Sun, 15 Oct 2023 00:00:00 -0400 Chinese Nursing Research; 10/15/2023<br/>(AN 173309653); ISSN: 10096493<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173319404&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:60f9d716-a03d-51e5-5b7b-5e5b5d7ed979 Sun, 15 Oct 2023 00:00:00 -0400 Nutrients; 10/15/2023<br/>(AN 173319404); ISSN: 20726643<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/37804554/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:3c5542fb-3ff4-9dc7-bdc6-8f5369702b59 Fri, 06 Oct 2023 20:00:00 -0400 CONCLUSIONS: Resource limitations and lack of nutritional screening and assessment prevent adequate nutritional intervention for children with cancer in Aotearoa, New Zealand. Akin to other high-income countries, there is a need to harmonize the management of nutritional challenges in children with cancer. This study provides a first step in establishing an evidence base to help support efforts to address this need in Aotearoa, New Zealand. <div><p style="color: #4aa564;">Nutrition. 2023 Dec;116:112218. doi: 10.1016/j.nut.2023.112218. Epub 2023 Sep 9.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: The purpose of this study was to investigate dietetic resources and current nutrition screening, assessment, and intervention practices in pediatric oncology centers in Aotearoa, New Zealand.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A national survey of the two specialist treatment centers and 14 shared care centers that provide care to childhood cancer patients in Aotearoa, New Zealand, was conducted.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The two specialist treatment centers in Aotearoa, New Zealand, were the only centers with a dedicated dietetic oncology full-time equivalent resource; this full-time equivalent resource was devoted to inpatient care. Only 5 shared care centers (44%) had access to general pediatric dietetic support. Dietetic cover for outpatients or day-stay patients and use of standardized nutrition screening and assessment tools were limited. Weight and height were commonly measured, but there was inconsistency in the frequency and recording of measurements. Nutrition interventions, including nutrition education, oral nutrition support, enteral nutrition, and intravenous nutrition, were available within all centers but criteria for initiating support varied. Common barriers to providing nutrition interventions included staff resourcing and ad hoc referral pathways. Awareness of the relevance and clinical benefit of nutrition in pediatric oncology was low. Suggestions to improve nutrition screening, assessment, and intervention within Aotearoa, New Zealand, included the creation of standardized screening and referral criteria.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Resource limitations and lack of nutritional screening and assessment prevent adequate nutritional intervention for children with cancer in Aotearoa, New Zealand. Akin to other high-income countries, there is a need to harmonize the management of nutritional challenges in children with cancer. This study provides a first step in establishing an evidence base to help support efforts to address this need in Aotearoa, New Zealand.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37804554/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">37804554</a> | DOI:<a href=https://doi.org/10.1016/j.nut.2023.112218>10.1016/j.nut.2023.112218</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=174632969&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:4743eeb8-c6d4-87aa-7bf8-088187fdd23b Sun, 01 Oct 2023 00:00:00 -0400 Acta Oto-Laryngologica; 10/01/2023<br/>(AN 174632969); ISSN: 00016489<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/37739717/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:511ebd5f-fed5-ecf9-2e34-600f19b83766 Thu, 21 Sep 2023 20:00:00 -0400 CONCLUSION: this work reinforces the high prevalence of malnutrition in oncological patients and the need to systematically track cancer patients throughout their disease/treatment trajectory, from admission to the hospital, to the day of admission to inpatient unit, and subsequent follow-up. We also propose expedited referrals to different specialized centres in nutritional support for cancer patients from the first day of hospitalization. Assessment of patients should always be accompanied by... <div><p style="color: #4aa564;">Clin Nutr ESPEN. 2023 Oct;57:637-646. doi: 10.1016/j.clnesp.2023.08.015. Epub 2023 Aug 18.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: malnutrition is a common phenomenon in people with cancer and can occur at all stages of the disease trajectory. Prevention, early identification of patients at risk of malnutrition, nutritional diagnosis, and personalized intervention, monitoring and follow-up are essential measures to minimize the occurrence of malnutrition and its consequences. This study aims to evaluate if current institutional practices regarding nutritional intervention guarantees nutritional/dietary care for cancer patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: adescriptive, analytical and longitudinal study was carried out, lasting five months, in a hospital inpatient surgical oncology unit. All patients admitted to the unit in the period between 1 March and 31 July 2022, who underwent nutritional screening at the time of admission to the service, were included. During hospitalization, they were subjected to periodic assessments of weight, body mass index and nutritional screening every 7 days until discharge.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: a total of 659 patients were admitted to the inpatient unit. The highest prevalence of malnutrition was observed in Head and Neck (37.6%), Genitourinary (30.8%) and Digestive (27.7%) cancers. Weight loss was especially significant in digestive, skin and sarcoma cancers, as well as genitourinary cancers, but not in breast cancer patients. During the hospitalization period, 14.0% of the hospitalized patients received nutrition-related nursing intervention, and 21.5% were referred for clinical dietetic intervention (by a registered dietitian).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: this work reinforces the high prevalence of malnutrition in oncological patients and the need to systematically track cancer patients throughout their disease/treatment trajectory, from admission to the hospital, to the day of admission to inpatient unit, and subsequent follow-up. We also propose expedited referrals to different specialized centres in nutritional support for cancer patients from the first day of hospitalization. Assessment of patients should always be accompanied by active referral capacity to a specialized and duly trained nutritional care team that is quick, proactive, and responsive.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37739717/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">37739717</a> | DOI:<a href=https://doi.org/10.1016/j.clnesp.2023.08.015>10.1016/j.clnesp.2023.08.015</a></p></div> https://pubmed.ncbi.nlm.nih.gov/37737437/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:196760dc-b83a-7842-97cd-71471686651e Thu, 21 Sep 2023 20:00:00 -0400 CONCLUSION: PNI can be used as an independent prognostic factor for both OS and DFS in patients lymph node-positive, stage II-III gastric cancer who will receive adjuvant chemotherapy. <div><p style="color: #4aa564;">J Gastrointest Cancer. 2023 Sep;54(3):962-969. doi: 10.1007/s12029-023-00972-x. Epub 2023 Sep 22.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PURPOSE: The prognostic nutritional index (PNI), like other systemic inflammatory markers, has been shown to be a prognostic factor in various cancer patients. In this study, we aimed to show whether PNI calculated before adjuvant chemotherapy is a prognostic factor for overall survival (OS) and disease-free survival (DFS) in patients with lymph node-positive stage II-III gastric cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The PNI was calculated using the albumin and lymphocyte count. The PNI cut-off value was found to be 39.5. They were divided into two groups as being ≤ 39.5 (PNI low group) and &gt; 39.5 (PNI high group).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Our study included 168 patients with lymph node-positive stage II-III gastric cancer who received adjuvant chemotherapy. Of the patients, 116 (69.0%) were 65 years or younger, and 52 (31.0%) were over 65 years old. Of the patients, 117 (69.6%) were pT3, 51 (30.4%) were pT4. Seventy-three (43.4%) patients had pN1-2 disease and 95 (56.6%) patients had pN3 disease. The number of stage II patients was 73 (43.5%) and the number of stage III patients was 95 (56.5%). There were 73 patients with PNI ≤ 39.5 and 95 patients with PNI &gt; 39.5. The mOS of the patients with low PNI group was 39.5 months, while the OS of the patients with high PNI group was 96.8 months (p = 0.002). In the group of patients with PNI low group, mDFS 24.4 months was significantly higher than those with PNI high group was 50.7 months (p = 0.021). The PNI score was statistically significant in univariate and multivariate analyzes for both DFS and OS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: PNI can be used as an independent prognostic factor for both OS and DFS in patients lymph node-positive, stage II-III gastric cancer who will receive adjuvant chemotherapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37737437/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">37737437</a> | DOI:<a href=https://doi.org/10.1007/s12029-023-00972-x>10.1007/s12029-023-00972-x</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=172419296&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:85e47d00-aa5a-fe2e-0507-71e3a06cdc20 Fri, 15 Sep 2023 00:00:00 -0400 Cancers; 09/15/2023<br/>(AN 172419296); ISSN: 20726694<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/37698001/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:123ed6f6-2e8b-a1f6-3727-d68013f49bc5 Mon, 11 Sep 2023 20:00:00 -0400 CONCLUSION: The CONUT score is related to short-term treatment outcomes, such as the length of intrahospital treatment and frequency and severity of postoperative complications, but also to long-term prognostic parameters. Early nutritional screening may be of prognostic significance. <div><p style="color: #4aa564;">Chirurgia (Bucur). 2023 Aug;118(4):391-398. doi: 10.21614/chirurgia.2023.v.118.i.4.p.391.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTRODUCTION/OBJECTIVE: Nutritional status is related to the prognosis of colorectal cancer (CRC) patients. The CONUT (The Controlling Nutritional Status) score is a recent nutritional marker. This study aimed to examine the association of preoperative CONUT score with overall survival (OS) and disease-free survival (DFS), while the secondary aim was to assess the importance of preoperative nutritional status for the development of postoperative complications.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The total number of CRC patients included in the study was 111. All patients underwent laboratory analyses within a week before surgery. Medical data were collected from archived data at the Zvezdara University Medical Centre. The CONUT score was analyzed in relation to the OS and DFS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Using the Kaplan-Meier survival curve and Log-rank test, a statistically significant difference in OS and DFS between groups of patients with different CONUT scores was observed. Patients with higher CONUT scores have a longer duration of hospitalization after surgery, a longer total length of stay, and a more severe degree of postoperative complications.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The CONUT score is related to short-term treatment outcomes, such as the length of intrahospital treatment and frequency and severity of postoperative complications, but also to long-term prognostic parameters. Early nutritional screening may be of prognostic significance.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37698001/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">37698001</a> | DOI:<a href=https://doi.org/10.21614/chirurgia.2023.v.118.i.4.p.391>10.21614/chirurgia.2023.v.118.i.4.p.391</a></p></div> https://pubmed.ncbi.nlm.nih.gov/37667936/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:cf3a919e-0ec9-90f7-6054-5123b524ec23 Mon, 04 Sep 2023 20:00:00 -0400 CONCLUSIONS: Sequential early enteral nutrition may be used for patients who undergo chemotherapy after esophageal cancer surgery to promote their early recovery and improve their quality of life and nutritional status. <div><p style="color: #4aa564;">Eur Rev Med Pharmacol Sci. 2023 Aug;27(16):7590-7596. doi: 10.26355/eurrev_202308_33411.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To study the effects of early sequential enteral nutrition (ESEN) therapy and early non-sequential enteral nutrition (EN) therapy on the nutritional status, recovery, and quality of life of patients who undergo postoperative chemotherapy for esophageal cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PATIENTS AND METHODS: The data of 90 patients who underwent postoperative chemotherapy for esophageal cancer in Gansu Provincial Cancer Hospital from January 2018 to June 2020 were analyzed retrospectively. Patients were divided the Test group and the Control group (n=45 each) based on the method of nutritional support. Patients in the Control group were treated with non-sequential early enteral nutrition and the Test group treated with sequential early enteral nutrition until the discharge. Nutritional status, recovery, and quality of life of the chemotherapy patients in the two groups were compared.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: After the intervention, the pre-protein, albumin and hemoglobin levels were higher in the Test group than in the control group (p&lt;0.05). Postoperative exhaustion, incision healing and length of hospital stay were significantly lower in the Test group than in the Control group (p&lt;0.05), while the scores on all dimensions of the short-form 36 health survey scale (SF-36) and the total score were higher than in the Control group (p&lt;0.05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Sequential early enteral nutrition may be used for patients who undergo chemotherapy after esophageal cancer surgery to promote their early recovery and improve their quality of life and nutritional status.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37667936/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">37667936</a> | DOI:<a href=https://doi.org/10.26355/eurrev_202308_33411>10.26355/eurrev_202308_33411</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=172322529&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:40849413-0a3d-c402-ca47-0344e127950f Fri, 01 Sep 2023 00:00:00 -0400 Canadian Journal of Dietetic Practice & Research; 09/01/2023<br/>(AN 172322529); ISSN: 14863847<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=169784600&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:5ed172ea-c59f-e682-ac50-8d33ad767df3 Fri, 01 Sep 2023 00:00:00 -0400 Nutrition & Cancer; 09/01/2023<br/>(AN 169784600); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=169784598&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:43bae988-0609-78e2-bd1a-e30a0160d921 Fri, 01 Sep 2023 00:00:00 -0400 Nutrition & Cancer; 09/01/2023<br/>(AN 169784598); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=169973854&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:43fa43a4-3641-4522-8de7-29899644e19d Fri, 01 Sep 2023 00:00:00 -0400 Nutrition Reviews; 09/01/2023<br/>(AN 169973854); ISSN: 00296643<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/37642430/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20240407232525&v=2.18.0.post9+e462414 pubmed: ((("Medical Oncology... urn:uuid:18ab4023-c623-3103-9e94-8828ca4f3474 Mon, 28 Aug 2023 20:00:00 -0400 CONCLUSION: This study highlights the importance of active treatment and nutritional support in improving survival outcomes for very elderly SCLC patients. The findings suggest that low PNI and lack of oncological treatment are associated with worse survival outcomes. Therefore, integrating nutritional assessment, interventions, and appropriate treatment strategies are crucial in managing lung cancer patients. Larger, multicenter studies are needed to validate these findings and explore... <div><p style="color: #4aa564;">Aging Male. 2023 Dec;26(1):2251573. doi: 10.1080/13685538.2023.2251573.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Small-cell lung cancer (SCLC) is a highly aggressive tumor with a high metastatic potential, particularly affecting current or former heavy smokers. Treatment typically involves chemotherapy, often combined with radiotherapy, and immunotherapy for extensive disease. Prophylactic cranial irradiation is recommended to reduce brain metastases. Elderly SCLC patients face unique challenges due to frailty and comorbidities, leading to increased risks of treatment-related toxicity and malnutrition. The prognostic nutritional index (PNI), a composite marker of nutritional and immune status, has shown promise in predicting outcomes in various malignancies. However, the optimal treatment approach for very elderly SCLC patients remains unclear, as they are often excluded from clinical trials.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: This study aimed to evaluate the survival outcomes of SCLC patients aged 75 years or older and their correlation with PNI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY DESIGN: Retrospective cohort study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The study retrospectively analyzed data from 71 SCLC patients aged ≥75 years, focusing on age, gender, smoking status, chronic diseases, performance status, clinical stage, treatment modality, and pretreatment PNI. Survival estimates were calculated using the Kaplan-Meier method, and multivariate Cox regression analysis was performed to identify independent predictors of overall survival (OS).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The results demonstrated that 26.8% of very elderly SCLC patients received no active treatment, resulting in a significantly shorter median survival time of 1.3 months. In contrast, patients who underwent aggressive treatment, such as palliative chemotherapy or chemotherapy plus radiotherapy, had significantly longer median survival times. Multivariate analysis revealed that receiving chemotherapy plus radiotherapy was associated with a significant survival benefit compared to no treatment. Furthermore, low PNI (≤40) was independently associated with decreased OS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This study highlights the importance of active treatment and nutritional support in improving survival outcomes for very elderly SCLC patients. The findings suggest that low PNI and lack of oncological treatment are associated with worse survival outcomes. Therefore, integrating nutritional assessment, interventions, and appropriate treatment strategies are crucial in managing lung cancer patients. Larger, multicenter studies are needed to validate these findings and explore potential interventions to optimize nutritional status and improve outcomes for elderly patients with SCLC.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37642430/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20240407232525&v=2.18.0.post9+e462414">37642430</a> | DOI:<a href=https://doi.org/10.1080/13685538.2023.2251573>10.1080/13685538.2023.2251573</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=169928231&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:ce3e09c1-3385-6ba4-f07a-d62cb7f17410 Tue, 01 Aug 2023 00:00:00 -0400 Cancers; 08/01/2023<br/>(AN 169928231); ISSN: 20726694<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=171296298&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:74c8e97b-8f5a-1256-8aa2-c39406698bad Tue, 01 Aug 2023 00:00:00 -0400 Chinese Nursing Research; 08/01/2023<br/>(AN 171296298); ISSN: 10096493<br/>CINAHL Complete